Form D · Other Health Care

Eclipse Toxicology, Ltd.

San Antonio, TX · CIK 0001635400

Offering snapshot reported Jan 21, 2016 · SEC filing

Reported sold
$1.28M
Offering amount: $2.16M
Investors reported
62
Form D · investor count
Minimum accepted
$12K
Reported outside-investor minimum
First sale
Mar 26, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$639K$1.28MMar 31, 2015: $126,000.00Mar 31, 2015Jan 21, 2016: $1,278,000.00Jan 21, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$126,000 → $1,278,000
  • Reported investors9 → 62

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 21, 2016Amendment$1,278,000$1,152,000vs Mar 31, 201562SEC filing
Mar 31, 2015Initial$126,000No comparison9SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-237026
Total amount sold does not include amounts relating to redeemed investors.

Source: Form D, filed Jan 21, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A Eclipse Lab Management, Llc Director
Lance Hupfield Executive
Abdou Mekebri Executive
Chris Shoup Executive
Bradley West Executive
William (Wade) White Executive
Richey Wyatt Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1077 Central Parkway S. Suite 300
San Antonio, TX, 78232